ORDER A SIMILAR PAPER NOW

1. Summarize the PICO(T) outcome evaluated by your selected article. The research presented must include pathophysiological findings that are current, thorough, and relevant to nursing practice.

 

 

PICOT: “In adults with type 2 diabetes (P), how does continuous glucose monitoring (I) compared to standard diabetes education (C) affect HbA1c levels (O) over a six-month period (T)

 

References

 

Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., … & MOBILE Study Group. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. Jama, 325(22), 2262-2272.

https://jamanetwork.com/journals/jama/fullarticle/2780593

 

PICO(T) Summary: Continuous Glucose Monitoring and HbA1c in Adults with Type 2 Diabetes

Population (P): Adults diagnosed with type 2 diabetes mellitus (T2DM) who are treated with basal insulin.

Intervention (I): Use of continuous glucose monitoring (CGM) devices to provide real-time glucose readings and trend data, allowing patients and providers to adjust therapy proactively.

Comparison (C): Standard diabetes education with self-monitoring of blood glucose (SMBG) using traditional fingerstick testing, without real-time continuous feedback.

Outcome (O): Reduction in glycated hemoglobin (HbA1c) levels, reflecting improved long-term glycemic control.

Time (T): 6-month study period.

---

Summary of Research Findings:

Martens et al. (2021) conducted a randomized clinical trial (MOBILE Study) evaluating whether CGM improves glycemic control in adults with T2DM on basal insulin therapy. Participants using CGM demonstrated a significant reduction in HbA1c levels compared to the control group using standard SMBG with diabetes education. Specifically, the mean HbA1c reduction was greater in the CGM group, indicating that real-time glucose feedback facilitates timely therapeutic adjustments, reduces hyperglycemic episodes, and encourages lifestyle modifications (diet, activity) that directly impact glycemic variability.

From a pathophysiological perspective, CGM helps address the dysregulated glucose metabolism in T2DM, which is characterized by insulin resistance and progressive β-cell dysfunction. By providing continuous feedback, CGM supports better alignment of insulin dosing with glycemic excursions, minimizing chronic hyperglycemia. This reduction in glucose variability is important because sustained high HbA1c levels contribute to microvascular and macrovascular complications, including neuropathy, retinopathy, nephropathy, and cardiovascular disease (Martens et al., 2021).

Implications for Nursing Practice:

• Patient Education and Self-Management: Nurses can leverage CGM data to teach patients about patterns in glucose fluctuations and reinforce self-management behaviors.

• Early Intervention: CGM allows nurses and clinicians to detect hyperglycemia or hypoglycemia trends earlier, facilitating timely insulin adjustments and reducing complication risks.

• Holistic Care Planning: Understanding the pathophysiological mechanisms behind improved HbA1c supports evidence-based interventions, emphasizing proactive glucose control rather than reactive management.

Conclusion:

The study provides strong evidence that continuous glucose monitoring improves HbA1c levels in adults with type 2 diabetes on basal insulin therapy, highlighting both clinical and pathophysiological benefits. CGM not only optimizes glycemic control but also empowers patients through actionable real-time data, making it a valuable tool for advanced nursing practice focused on prevention and chronic disease management.

---

Reference:

Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., … & MOBILE Study Group. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial. JAMA, 325(22), 2262–2272. https://jamanetwork.com/journals/jama/fullarticle/2780593

 

ORDER A SIMILAR PAPER NOW